Institution
Sendai Kousei Hospital
JPhealthcare
Recent research
- Health & MedicineOpen access
Background/Aim: Ultra-high dose rate (FLASH) radiotherapy has been reported to reduce normal tissue toxicity while maintaining tumor control. However, whether proton FLASH induces different biological responses in the entrance versus spread-out Bragg peak (SOBP) regions under con...
- Health & MedicineOpen access
Abstract Background In the Phase 3 DeLLphi-304 trial, tarlatamab significantly improved overall survival (OS) over chemotherapy for small-cell lung cancer (SCLC) progressed after platinum-based chemotherapy. We report efficacy and safety in the Japanese subpopulation. Methods Pat...